Literature DB >> 14687727

Determination of CD59 protein in normal human serum by enzyme immunoassay, using octyl-glucoside detergent to release glycosyl-phosphatidylinositol-CD59 from lipid complex.

A P G Landi1, A B Wilson, A Davies, P J Lachmann, V P L Ferriani, D J Seilly, A I Assis-Pandochi.   

Abstract

In this study we have optimised the enzyme immunoassay (ELISA) to quantify CD59 antigen in human serum or plasma. The glycosyl-phosphatidylinositol (GPI)-linked form of CD59 is known to complex with serum high-density lipoprotein. For ELISA optimisation, therefore, we investigated the effect of detergents, added to the sample diluent, on the determined values of CD59. Values obtained in the presence of octyl-glucoside (OG) for 20 adults aged 18-35 years and 17 children 1-5 years old were, respectively, 33-119 ng/ml (mean +/- S.D.: 66+/-22 ng/ml) and 37-143 ng/ml (76+/-33 ng/ml). These results were higher than those measured without OG and were in contrast with published results showing absence, or eight to nine times lower levels, of the protein in serum. A known range for serum concentrations of CD59 in healthy individuals will establish an important reference point for clinical work and for the investigation of diseases involving the complement membrane attack complex (MAC) and its regulation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14687727     DOI: 10.1016/j.imlet.2003.07.001

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  7 in total

1.  Complement Activation in Patients With Heat-Related Illnesses: Soluble CD59 Is a Novel Biomarker Indicating Severity of Heat-Related Illnesses.

Authors:  Yuki Nakamura; Koichiro Sueyoshi; Yukari Miyoshi; Tadashi Ishihara; Yohei Hirano; Yutaka Kondo; Yoko Kuroda; Kazuhisa Iwabuchi; Ken Okamoto; Hiroshi Tanaka
Journal:  Crit Care Explor       Date:  2022-04-21

2.  Patients with ovarian carcinoma excrete different altered levels of urine CD59, kininogen-1 and fragments of inter-alpha-trypsin inhibitor heavy chain H4 and albumin.

Authors:  Siti S Abdullah-Soheimi; Boon-Kiong Lim; Onn H Hashim; Adawiyah S Shuib
Journal:  Proteome Sci       Date:  2010-11-17       Impact factor: 2.480

3.  A specific and sensitive assay for blood levels of glycated CD59: a novel biomarker for diabetes.

Authors:  Pamela Ghosh; Rupam Sahoo; Anand Vaidya; Sonia Cantel; Amol Kavishwar; Allison Goldfine; Neil Herring; Lynn Bry; Michael Chorev; Jose A Halperin
Journal:  Am J Hematol       Date:  2013-06-20       Impact factor: 10.047

4.  Glycation of the complement regulatory protein CD59 is a novel biomarker for glucose handling in humans.

Authors:  Pamela Ghosh; Anand Vaidya; Rupam Sahoo; Allison Goldfine; Neil Herring; Lynn Bry; Michael Chorev; Jose A Halperin
Journal:  J Clin Endocrinol Metab       Date:  2014-03-14       Impact factor: 5.958

5.  Soluble CD59 in peritoneal dialysis: a potential biomarker for peritoneal membrane function.

Authors:  Bernardo Faria; Mariana Gaya da Costa; Carla Lima; Loek Willems; Ricardo Brandwijk; Stefan P Berger; Mohamed R Daha; Manuel Pestana; Marc A Seelen; Felix Poppelaars
Journal:  J Nephrol       Date:  2020-12-11       Impact factor: 3.902

6.  Plasma-glycated CD59 as an early biomarker for gestational diabetes mellitus: prospective cohort study protocol.

Authors:  Chloe Andrews; Michelle Toth-Castillo; Huseyin Aktas; Miguel-Angel Luque Fernandez; Steven Koon Wong; Sarbattama Sen; Jose Halperin
Journal:  BMJ Open       Date:  2022-04-20       Impact factor: 3.006

7.  Soluble CD59 is a Novel Biomarker for the Prediction of Obstructive Chronic Lung Allograft Dysfunction After Lung Transplantation.

Authors:  Kevin Budding; Eduard A van de Graaf; Tineke Kardol-Hoefnagel; Johanna M Kwakkel-van Erp; Bart D Luijk; Erik-Jan D Oudijk; Diana A van Kessel; Jan C Grutters; C Erik Hack; Henderikus G Otten
Journal:  Sci Rep       Date:  2016-05-24       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.